Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Jul;25(1):103–109. doi: 10.1128/iai.25.1.103-109.1979

Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans.

T C Chow, K R Beutner, P L Ogra
PMCID: PMC414427  PMID: 478632

Abstract

Humoral and cell-mediated immunity (CMI) were evaluated in groups of school children after immunization with inactivated influenza virus vaccines. A conventional biphasic strain (H3ChN2Ch) of Port Chalmers influenza virus (X-41), a recombinant influenza virus specific for the neuraminidase antigen (Heq1N2Ch) of Port Chambers influenza A virus (X-42), and a placebo were employed for immunization. The techniques of hemagglutination inhibition and neuraminidase inhibition were used to determine serum antibody titers. The CMI responses were evaluated by the in vitro lymphocyte transformation assay employing HavN2Ch, Heq1Neq1, H3ChNeq1, and H3ChN2Ch influenza A virus strains as stimulants. Specific HAI antibody and CMI responses to H3Ch were observed in X-41 but not in X-42 vaccinees. Specific anti-neuraminidase antibodies and CMI responses to N2Ch were manifested by both X-41 and X-42 vaccinees. Immunization with the placebo resulted in no influenza-specific immune responses. The CMI response was first detectable 10 days after immunization and then declined. These observations demonstrate the induction of CMI responses to the HA and NA influenza surface antigens after immunization. These responses may be important in antiviral immunity and the recovery from influenza infection.

Full text

PDF
105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMINOFF D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961 Nov;81:384–392. doi: 10.1042/bj0810384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson M. J., Bainbridge D. R., Pattison J. R., Heath R. B. Cell-mediated immunity to Sendai virus infection in mice. Infect Immun. 1977 Jan;15(1):239–244. doi: 10.1128/iai.15.1.239-244.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beutner K. R., Tiku M. L., Ogra P. L. Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers. Infect Immun. 1978 Aug;21(2):480–488. doi: 10.1128/iai.21.2.480-488.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chess L., MacDermott R. P., Schlossman S. F. Immunologic functions of isolated human lymphocyte subpopulations. II. Antigen triggering of T and B cells in vitro. J Immunol. 1974 Oct;113(4):1122–1127. [PubMed] [Google Scholar]
  5. Dowdle W. R., Marine W. M., Coleman M., Knez V. Haemagglutinin relationships of Hong Kong(H3) and Asian(H2) influenza strains delineated by antigen-specific recombinants. J Gen Virol. 1972 Aug;16(2):127–134. doi: 10.1099/0022-1317-16-2-127. [DOI] [PubMed] [Google Scholar]
  6. HORSFALL F. L., Jr, TAMM I. Fractional dilution procedure for precise titration of hemagglutinating viruses and hemagglutination-inhibiting antibodies. J Immunol. 1953 Mar;70(3):253–259. [PubMed] [Google Scholar]
  7. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jordan G. W., Merigan T. C. Cell-mediated immunity to varicella-zoster virus: in vitro lymphocyte responses. J Infect Dis. 1974 Nov;130(5):495–501. doi: 10.1093/infdis/130.5.495. [DOI] [PubMed] [Google Scholar]
  9. Kilbourne E. D., Laver W. G., Schulman J. L., Webster R. G. Antiviral activity of antiserum specific for an influenza virus neuraminidase. J Virol. 1968 Apr;2(4):281–288. doi: 10.1128/jvi.2.4.281-288.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LOOSLI C. G., HAMRE D., BERLIN B. S. Air-borne influenza virus A infections in immunized animals. Trans Assoc Am Physicians. 1953;66:222–230. [PubMed] [Google Scholar]
  11. Lay W. H., Mendes N. F., Bianco C., Nussenzweig V. Binding of sheep red blood cells to a large population of human lymphocytes. Nature. 1971 Apr 23;230(5295):531–532. doi: 10.1038/230531a0. [DOI] [PubMed] [Google Scholar]
  12. Morag A., Beutner K. R., Morag B., Ogra P. L. Development and characteristics of in-vitro correlates of cellular immunity to rubella virus in the systemic and mucosal sites in guinea pigs. J Immunol. 1974 Dec;113(6):1703–1709. [PubMed] [Google Scholar]
  13. Morag A., Morag B., Bernstein J. M., Beutner K., Ogra P. L. In vitro correlates of cell-mediated immunity in human tonsils after natural or induced Rubella virus infection. J Infect Dis. 1975 Apr;131(4):409–416. doi: 10.1093/infdis/131.4.409. [DOI] [PubMed] [Google Scholar]
  14. Murphy B. R., Kasel J. A., Chanock R. M. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med. 1972 Jun 22;286(25):1329–1332. doi: 10.1056/NEJM197206222862502. [DOI] [PubMed] [Google Scholar]
  15. Ogra P. L., Chow T., Beutner K. R., Rubi E., Strussenberg J., DeMello S., Rizzone C. Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans. J Infect Dis. 1977 Apr;135(4):499–506. doi: 10.1093/infdis/135.4.499. [DOI] [PubMed] [Google Scholar]
  16. Pauly J. L. A simple screening assay for substances affecting lymphocyte reactivity. J Immunol Methods. 1976;12(1-2):141–147. doi: 10.1016/0022-1759(76)90104-6. [DOI] [PubMed] [Google Scholar]
  17. Pauly J. L., Han T. Whole blood microculture assay of human lymphocyte function. J Lab Clin Med. 1976 Nov;88(5):864–872. [PubMed] [Google Scholar]
  18. Ruben F. L., Jackson G. G., Gotoff S. P. Humoral and cellular response in humans after immunization with influenza vaccine. Infect Immun. 1973 Apr;7(4):594–596. doi: 10.1128/iai.7.4.594-596.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schild G. C. Antibody against influenza A2 virus neuraminidase in human sera. J Hyg (Lond) 1969 Jun;67(2):353–365. doi: 10.1017/s0022172400041759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schulman J. L., Khakpour M., Kilbourne E. D. Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol. 1968 Aug;2(8):778–786. doi: 10.1128/jvi.2.8.778-786.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shvartsman Y. S., Zykov M. P. Secretory anti-influenza immunity. Adv Immunol. 1976;22:291–330. doi: 10.1016/s0065-2776(08)60551-9. [DOI] [PubMed] [Google Scholar]
  22. Small P. A., Jr, Waldman R. H., Bruno J. C., Gifford G. E. Influenza infection in ferrets: role of serum antibody in protection and recovery. Infect Immun. 1976 Feb;13(2):417–424. doi: 10.1128/iai.13.2.417-424.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Steele R. W., Hensen S. A., Vincent M. M., Fuccillo D. A., Bellanti J. A. Development of specific cellular and humoral immune responses in children immunized with live rubella virus vaccine. J Infect Dis. 1974 Nov;130(5):449–453. doi: 10.1093/infdis/130.5.449. [DOI] [PubMed] [Google Scholar]
  24. Sullivan J. L., Mayner R. E., Barry D. W., Ennis F. A. Influenza virus infection in nude mice. J Infect Dis. 1976 Jan;133(1):91–94. doi: 10.1093/infdis/133.1.91. [DOI] [PubMed] [Google Scholar]
  25. Suzuki F., Oya J., Ishida N. Effect of antilymphocyte serum on influenza virus infection in mice. Proc Soc Exp Biol Med. 1974 May;146(1):78–84. doi: 10.3181/00379727-146-38047. [DOI] [PubMed] [Google Scholar]
  26. Virelizier J. L. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol. 1975 Aug;115(2):434–439. [PubMed] [Google Scholar]
  27. Virelizier J. L., Postlethwaite R., Schild G. C., Allison A. C. Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med. 1974 Dec 1;140(6):1559–1570. doi: 10.1084/jem.140.6.1559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. WARREN L. The thiobarbituric acid assay of sialic acids. J Biol Chem. 1959 Aug;234(8):1971–1975. [PubMed] [Google Scholar]
  29. Waldman R. H., Spencer C. S., Johnson J. E., 3rd Respiratory and systemic cellular and humoral immune responses to influenza virus vaccine administered parenterally or by nose drops. Cell Immunol. 1972 Feb;3(2):294–300. doi: 10.1016/0008-8749(72)90168-2. [DOI] [PubMed] [Google Scholar]
  30. Webster R. G., Laver W. G., Kilbourne E. D. Reactions of antibodies with surface antigens of influenza virus. J Gen Virol. 1968 Dec;3(3):315–326. doi: 10.1099/0022-1317-3-3-315. [DOI] [PubMed] [Google Scholar]
  31. Webster R. G., Laver W. G. Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus. J Immunol. 1967 Jul;99(1):49–55. [PubMed] [Google Scholar]
  32. Wyde P. R., Couch R. B., Mackler B. F., Cate T. R., Levy B. M. Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect Immun. 1977 Jan;15(1):221–229. doi: 10.1128/iai.15.1.221-229.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES